alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid has been researched along with perampanel in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 3 (60.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kusano, K; Mano, Y; Takenaka, O | 1 |
| Schaefer, SM; Wadhwa, A | 1 |
| Bellingacci, L; Citraro, R; Costa, C; De Caro, C; De Sarro, G; Di Filippo, M; Leo, A; Mancini, A; Megaro, A; Russo, E; Sciaccaluga, M; Tallarico, M; Tozzi, A | 1 |
| Reeta, KH; Sharma, H; Sharma, U; Singh, S; Suri, V | 1 |
| Knake, S; Kovac, S; Rosenow, F; Strzelczyk, A; van der Goten, M; von Podewils, F; Willems, LM; Zöllner, JP | 1 |
5 other study(ies) available for alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid and perampanel
| Article | Year |
|---|---|
High-performance liquid chromatography-tandem mass spectrometry method for the determination of perampanel, a novel α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonist in human plasma.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Calibration; Chromatography, High Pressure Liquid; Humans; Nitriles; Plasma; Pyridones; Receptors, AMPA; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry | 2015 |
Successful Treatment of Primary Orthostatic Tremor Using Perampanel.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Anticonvulsants; Clonazepam; Dizziness; Female; Humans; Middle Aged; Nitriles; Pyridones; Receptors, AMPA; Treatment Outcome; Tremor | 2019 |
Non-competitive AMPA glutamate receptors antagonism by perampanel as a strategy to counteract hippocampal hyper-excitability and cognitive deficits in cerebral amyloidosis.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Amyloid beta-Peptides; Animals; Cerebral Amyloid Angiopathy; Cognition; Cognitive Dysfunction; Excitatory Amino Acid Antagonists; Hippocampus; Mice; Receptors, AMPA | 2023 |
AMPA receptor modulation through sequential treatment with perampanel and aniracetam mitigates post-stroke damage in experimental model of ischemic stroke.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Anti-Inflammatory Agents; Infarction, Middle Cerebral Artery; Ischemic Stroke; Models, Theoretical; Neuroprotective Agents; Rats; Receptors, AMPA; Stroke | 2023 |
Adverse Event Profiles of Antiseizure Medications and the Impact of Coadministration on Drug Tolerability in Adults with Epilepsy.
Topics: Adult; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Anticonvulsants; Epilepsy; Humans; Levetiracetam; Retrospective Studies; Topiramate; Valproic Acid; Zonisamide | 2023 |